Bio-Path Holdings, Inc. (BPTH) Social Stream
BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BPTH.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
BPTH's average price target has moved down $7 over the prior 30 months.
BPTH reports an average of 327.99% for its upside potential over the past 35 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BPTH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, BPTH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.
- BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 6.9% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, BIO-PATH HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 279.17% of them.
- In terms of how BIO-PATH HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 65.51% of that group.
- BIO-PATH HOLDINGS INC's average analyst price target is greater than 67.28% of Healthcare stocks.
Make investment decisions regarding BPTH using the data that counts. Try POWR Ratings for free.